top of page
AdobeStock_317049552_copy2.jpg
Precision Exosome Selection Revolutionary Diagnostics
Promising                 data, 30 years of biosensor manufacturing experience combined with the current trend in AI could bring a new era in low cost early cancer screening
Exosomes for Early Stage Cancer Diagnostics
​Exosomes are nanoparticles that are released and received by nearly all cells in the body. These highly-evolved vesicles act as one of our body’s communication systems, same for cancer cells, delivering important molecular payloads from cell to cell. 
Exosomes Cancer
Targets
targets.png

*Light intensity represents future work

Cancer Screening.png

Winning Cancer Starts with Early Detection 

The exosome research field has exploded in the last decade, and SOL Bio Corp. has remained at the forefront of the field, developing a highly efficient cancer isolation protocol for liquid biopsy tests using exosomes
AdobeStock_436306186.jpeg

© SOL Bio Corp., 2019

Head Office, R&D Center

STE 510, 27, Seongsui-ro 7-gil, Seongdong-gu, Seoul, South Korea 04780

서울특별시 성동구 성수이로7길 27 서울숲코오롱디지털타워 2차, 510호

GMP Manufacturing Facility

STE 610, 25, Seongsuil-ro 4-gil, Seongdong-gu, Seoul, South Korea 04780

서울특별시 성동구 성수일로4길 25 서울숲코오롱디지털타워 1차, 610호

       

 

T: +82 2-466-2796

F: +82 2-466-2797

M: info@sol-bio.com

© Copyright
bottom of page